Dobrachinski, Fernando
Gerbatin, Rogério R.
Sartori, Gláubia
Golombieski, Ronaldo M.
Antoniazzi, Alfredo
Nogueira, Cristina W.
Royes, Luiz F.
Fighera, Michele R.
Porciúncula, Lisiane O.
Cunha, Rodrigo A.
Soares, Félix A. A. http://orcid.org/0000-0002-3948-1273
Funding for this research was provided by:
Fundação para a Ciência e a Tecnologia (POCI-01-0145-FEDER-007440, PTDC/NEU-NMC/4154/2016)
Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS/PRONEM 11/2029-1)
Centro 2020 (Maratona da Saúde, GAI-FMUC and Banco Santander-Totta e ERDF) (CENTRO-01-0145-FEDER-000008: BrainHealth 2020)
Article History
Received: 2 May 2018
Accepted: 2 August 2018
First Online: 13 August 2018
Compliance with Ethical Standards
: This study was approved by the Committee on the Ethics of Animal Experiments of the Federal University of Santa Maria, Brazil (Permit Number: 153/2014) and carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The Ethics Committee imposed the selection of representative drug concentrations, based on our previous experience in using all tested drugs, to reduce the number of animals used in the experiments, while making all efforts to minimize animal suffering.
: The authors declare that they have no conflict of interest.